A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

Kloeze, 1967, Influence of prostaglandins on platelet aggregation, 241

Kloeze, 1969, Relationship between chemical structure and platelet-aggregation activity of prostaglandins, Biochim. Biophys. Acta., 187, 285, 10.1016/0005-2760(69)90001-0

Smith, 1974, Prostaglandin D2 inhibits the aggregation of human platelets, Thromb. Res., 5, 291, 10.1016/0049-3848(74)90168-6

Willis, 1974, An endoperoxide aggregator (LASS) formed in platelets in response to thrombotic stimuli, Prostaglandins, 8, 453, 10.1016/0090-6980(74)90062-8

Hamberg, 1974, Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation, Proc. Nat. Acad. Sci. U.S.A., 71, 345, 10.1073/pnas.71.2.345

Hamberg, 1975, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides, 72, 2994

Needleman, 1976, Identification of an enzyme in platelet microsomes which generate thromboxane A2 from prostaglandins, Nature, 261, 558, 10.1038/261558a0

Moncada, 1976, Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition, Prostaglandins, 12, 323, 10.1016/0090-6980(76)90014-9

Bunting, 1976, The effects of prostaglandin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations, Br. J. Pharmacol., 57, 462P

Moncada, 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature, 10.1038/263663a0

Gryglewski, R., Bunting, S., Moncada, S., Flower, R.J. and J.R. Vane. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 12: 685–713

Born, 1962, Aggregation of blood platelets by adenosine diphosphate and its reversal, Nature, 194, 927, 10.1038/194927b0

Lowry, 1951, Protein measurement with the folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Flower, 1976, The importance of phospholipase A2 in prostaglandin biosynthesis, Biochem. Pharmacol., 25, 285, 10.1016/0006-2952(76)90216-1

Vargaftig, 1972, Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by administration of bradykinin, J. Pharm. Pharmacol., 24, 159, 10.1111/j.2042-7158.1972.tb08953.x

Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature, 231, 232

Marcus, 1969, Lipid composition of subcellular particles of human blood platelets, J. Lipid Res., 10, 108, 10.1016/S0022-2275(20)42654-9

Smith, 1974, Platelets, Vol. II, 293

Ojima, 1976, Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO 747, Vol. II, 781

Salzman, 1974, Prostaglandins, cyclic AMP, and platelet function, Thromb. Diath. Haemorrh., 311

Mills, 1974, Stimulation of human platelet adenylate cyclase by prostaglandin D2, Thromb. Res., 5, 401, 10.1016/0049-3848(74)90176-5

Pace-Asciak, 1971, A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenates, Biochemistry, 10, 3657, 10.1021/bi00796a004

Pace-Asciak, 1976, Isolation, structure and biosynthesis of 6-Ketoprostaglandin F1α in the rat stomach, J. Amer. Chem. Soc., 98, 2348, 10.1021/ja00424a065

Pace-Asciak, 1971, Polyhydroxy cyclic ethers formed from tritiated arachidonic acid by acetone powders of sheep seminal vesicles, Biochemistry, 10, 364, 10.1021/bi00796a005

Pace-Asciak, 1976, Transformation of prostaglandin G2 into 6(9)-oxy-11,15-dihydroxy-prosta-7, 13-dienoic acid by the rat stomach fundus, Biochim. Biophys. Acta., 424, 323, 10.1016/0005-2760(76)90200-9

Dawson, 1976, Release of novel prostaglandins and thromboxane after immunological challenge of guinea pig lung, Nature, 262, 699, 10.1038/262699a0

Mustard, 1962, Effect of intravenous phospholipid containing phosphatidyl serine on blood clotting with particular reference to Russell's viper venom time, Nature, 196, 1063, 10.1038/1961063a0

Nishizawa, 1966, Effect of a natural phosphatidyl serine fraction on blood coagulation, platelet aggregation and homeostasis, Br. J. Haematol., 16, 487, 10.1111/j.1365-2141.1969.tb00427.x

Baumgartner, 1972, Platelet interaction with vascular structures, Thromb. Diath. Haemorrh., 161

Baumgartner, 1974, Morphometric quantitation of adherence of platelets to an artificial surface and components of connective tissue, Thromb. Diath. Haemorrh., 38

Mills, 1972, Drugs that affect platelet behaviour, Clin. Haematol., 1, 295

Salzman, 1976, Prostaglandins and platelet function, Vol. II, 767

Spaet, 1966, Vascular wall in pathogenesis of thrombosis, Thromb. Diath. Haemorrh., 67

Spaet, 1969, Vascular endothelium and thrombogenesis, 417

Sheppard, 1971, Platelet adhesion in the rabbit abdominal aorta following the removal of the endothelium: a scanning and transmission electron microscopical study, 176, 427

Mustard, 1970, Factors influencing platelet function adhesion, release and aggregation, Pharmacol. Rev., 22, 97

Harman, 1966, Free radical theory of ageing: Free radical reaction in serum, J. Gerontol., 21, 560, 10.1093/geronj/21.4.560

Slater, 1972

Glavind, 1952, Studies on the role of lipoperoxides in human pathology, 30, 1

Zalkin, 1962, Increased lysosomal enzymes in muscular dystrophy of vitamin E-deficient rabbits, 237, 2678

O'Brien, 1968, Effect of anti-inflammatory agents on platelets, Lancet, I, 894, 10.1016/S0140-6736(68)90242-0

Hamberg, 1974, Prostaglandin endoperoxides, 71, 3400

Elwood, 1974, A randomized controlled trial of acetyl-salicyclic acid in the secondary prevention of mortality from myocardial infarction, Br. Med. J., 1, 436, 10.1136/bmj.1.5905.436

Kulkarni, P.S., Roberts, R. and P. Needleman. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins 12: 237–353.